The Debate on Acetaminophen Use in Pregnancy and Neurodevelopmental Disorders: Facts or Fiction?

Register to join us for our next CSPT members' webinar!

“The Debate on Acetaminophen Use in Pregnancy and Neurodevelopmental Disorders: Facts or Fiction?”

Hear from

Anick Bérard, PhD FCAHS FISPE 

Canada Research Chair Tier 1 on Medications and Pregnancy, Faculty of Pharmacy, University of Montreal. Principal Investigator in Canadian Mother-Child Initiative on Drug Safety in Pregnancy. Director at Research Unit on Medications and Pregnancy, Research Center - CHU Sainte-Justine

Dr. Bérard has cross-training in epidemiology, pharmacoepidemiology, and genetics from McGill University, and Harvard Medical School. She is full professor of perinatal epidemiology at the University of Montreal, Faculty of Pharmacy, and CHU Ste-Justine in Montreal; and adjunct professor at the Faculty of Medicine of the Université Claude Bernard in Lyon, France, and at the Université Paris Cité, Paris, France. Dr Bérard holds a Canada Research Chair Tier 1 on Medications and Pregnancy; and University of Montreal’s Louis-Boivin research chair on « Medications, pregnancy and lactation ». Dr Bérard is a Fellow of the Canadian Academy of Health Science, and of the International Society of Pharmacoepidemiology; and a voting member of the Birth Defects Research Society.

Dr Bérard is the principal investigator of the Canadian Mother-Child Initiative on Drug Safety in Pregnancy (CAMCCO Research/Training/Knowledge Dissemination). She has published over 230 scientific papers, and 2 patents; she has obtained over 37 million dollars in funding from CIHR, CFI, and FRQS as principal investigator. She recently received a Most Distinguished Scientist Award from the Society for Birth Defects Research and Prevention for her work on antidepressants, maternal depression, and pregnancy; and a research career award from the Association of Faculties of Pharmacy of Canada. She is a member of the Agence Nationale sur la Sécurité des Médicaments in France, where she is involved in decision making regarding medication safety in pregnancy, including antidepressants.